Business Wire

NY-ALVAREZ-&-MARSAL

18.1.2023 07:01:35 CET | Business Wire | Press release

Share
Alvarez & Marsal Announces 2023 Managing Director Promotions

Leading global professional services firm Alvarez & Marsal (A&M) has announced the promotion of 85 professionals across Brazil, Benelux, Canada, Cayman Islands, China, France, Germany, India, Spain, United Arab Emirates, United Kingdom and the United States, to the position of Managing Director.

Tony Alvarez II and Bryan Marsal, A&M’s Co-Founders, stated, “Congratulations to all our newly promoted Managing Directors. Their commitment to help clients maximize value and drive change amid ongoing macro-economic challenges builds upon our legacy of operational excellence while advancing our results-oriented mission. Their proven ability to help solve for clients’ complex problems is critical to the firm’s success and growth moving forward.”

Asia

Henry Chambers, Hong Kong

Eden Chen, Shanghai

Sally Sun, Hong Kong

Brazil

Pedro Bortolotto, São Paulo

Marcelo Compte, São Paulo

Rodrigo Domingues, São Paulo

Lilian Giorgi, São Paulo

Rodrigo Hong, São Paulo

Henrique Kanashiro, São Paulo

Rafael Mendonca Rodrigues, São Paulo

Fabio Missiato, São Paulo

Corporate Performance Improvement

Tiffany Guthrie, Houston

Mike Hall, San Francisco

John McKinnis, Dallas

Sam Rudkin, Atlanta

Consumer and Retail Group

Kenneth Cochran, Charlotte

Jeffrey Dwyer, Chicago

Lakshman Lakshmanan, Dallas

Chad Lusk, Chicago

Joanna Rangarajan, New York

Global Disputes and Investigations

Lee Betteridge, London

Gary Foster, London

EMEA – Performance Improvement

Private Equity Performance Improvement

Nicola Barbini, London

Chris Gobby, London

Britta Mittler, Frankfurt

Till Prinz, Dusseldorf

Tim Veen, Munich

Gerardo Villalba Bello, Madrid

Ysabel Gaspar Zayco, London

Financial Services Industry

Robert Bradbury, London

Dominic Roope, London

Corporate Transformation

Jatin Arora, Dubai

Mark Bennett, Paris

Daran Hopper, London

Dirk Naujokat, Munich

Steve Trainor, London

Diana Wong, London

EMEA Restructuring

Insolvency

Barry Lynch, Grand Cayman

Helen Skeates, London

Turnaround

David Johnston, London

José Miguel Gómez Rivas, Madrid

Middle East

Bill Ozturk, Dubai

Environmental, Social and Governance (ESG)

Stephanie Weiler, Chicago

Healthcare Industry Group

JoyAnn Book, Phoenix

Bianca A. Briola Charlotte

David Nidetz, Detroit

Rich Rieger, Chicago

India

Anup Gandhi, Mumbai

Pranav Sheth, Mumbai

Infrastructure & Capital Projects

Sue Frost, Washington, D.C.

Alan Richard, Washington, D.C.

Private Equity Performance Group

Kent Edgerton, Nashville

Jana Gold, Washington, D.C.

Brad Howard, New York

Larry Thomas, Tampa

Klaus Weisenberger, San Francisco

Public Sector

Daniel Harlan, Washington, D.C

Restructuring & Turnaround (North America)

Taylor Atwood, Dallas

Matthew Davidson, Detroit

Chad Ellison, Calgary

Kamila Khairoullina, New York

Mark Sidorenkov, Phoenix

Jeff Sielinski, Detroit

Michael Zembillas, Atlanta

Global Taxand

Simon Bernstein, New York

Stephanie Doughty, Houston

Michael Farkas, New York

Simon Gore, London

Jack Hollyman, London

Jac Emilio Martinez, Miami

Joseph Plati, New York

Brendan Sinnott, New York

Katya Umanskaya, Los Angeles

Global Transaction Advisory Group

Anuj Astir, New York

Nout Brugman, Amsterdam

David Cho, Chicago

Vitor Garcia, Sao Paulo

Jimmy Glenn, Atlanta

Nick Lynch, London

Jai Tandan, Mumbai

Rhett Taylor, Nashville

Nick Thoele, New York

Cedric Zana, Paris

Valuation Services

Cole Corbin, New York

Steven Fischoff, Chicago

About Alvarez & Marsal

Companies, investors and government entities around the world turn to Alvarez & Marsal (A&M) for leadership, action and results. Privately held since its founding in 1983, A&M is a leading global professional services firm that provides advisory, business performance improvement and turnaround management services. When conventional approaches are not enough to create transformation and drive change, clients seek our deep expertise and ability to deliver practical solutions to their unique problems.

With over 7,000 people across five continents, we deliver tangible results for corporates, boards, private equity firms, law firms and government agencies facing complex challenges. Our senior leaders, and their teams, leverage A&M’s restructuring heritage to help companies act decisively, catapult growth and accelerate results. We are experienced operators, world-class consultants, former regulators and industry authorities with a shared commitment to telling clients what’s really needed for turning change into a strategic business asset, managing risk and unlocking value at every stage of growth.

To learn more, visit: AlvarezandMarsal.com. Follow A&M on LinkedIn, Twitter, and Facebook.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230117005828/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release

MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot

Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release

Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me

BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release

Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release

Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely

MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release

The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye